- Open Access
Pollen Allergies in Humans and their Dogs, Cats and Horses: Differences and Similarities
Clinical and Translational Allergyvolume 5, Article number: 15 (2015)
Both humans and their most important domestic animals harbor IgE and a similar IgE receptor repertoire and expression pattern. The same cell types are also involved in the triggering or regulation of allergies, such as mast cells, eosinophils or T-regulatory cells. Translational clinical studies in domestic animals could therefore help cure animal allergies and at the same time gather knowledge relevant to human patients. Dogs, cats and horses may spontaneously and to different extents develop immediate type symptoms to pollen allergens. The skin, nasal and bronchial reactions, as well as chronic skin lesions due to pollen are in principle comparable to human patients. Pollen of various species most often causes allergic rhinitis in human patients, whereas in dogs it elicits predominantly eczematous lesions (canine atopic dermatitis), in horses recurrent airway obstruction or hives as well as pruritic dermatitis, and in cats bronchial asthma and so-called cutaneous reactive patterns (eosinophilic granuloma complex, head and neck pruritus, symmetric self-induced alopecia). In human allergy-specific IgE detection, skin tests or other allergen provocation tests should be completed. In contrast, in animals IgE and dermal tests are regarded as equally important and may even replace each other. However, for practical and economic reasons intradermal tests are most commonly performed in a specialized practice. As in humans, in dogs, cats and horses allergen immunotherapy leads to significant improvement of the clinical symptoms. The collected evidence suggests that canines, felines and equines, with their spontaneous allergies, are attractive model patients for translational studies.
Human pollen allergy
It is of great interest to compare the sensitization to pollen allergens and subsequent clinical manifestations between human patients and their domestic animals, such as dogs, cats and horses . Generally, the sensitization to pollen allergens is high in Europe and ranges up to almost 70% in allergic human subjects . For standard diagnosis the skin prick test (SPT) is an important cornerstone. In SPT an allergen is brought into the skin only epicutaneously, and a wheal and flare diameter above the positive control, or at 3 mm diameter, are counted as positive. The atopy patch test is a possible alternative . Depending on the geographical exposure, accross Europe a panel of 18 allergens is needed for diagnosis, and there are efforts to standardize the panel of allergens used for diagnosis . The diagnosis in human allergic patients is therefore based on history, skin test and determination of allergen-specific IgE, completed by nasal conjunctival, or pulmonary function tests (Figure 1). Whereas the overwhelming number of tests are still performed with allergen extracts, component-resolved allergy diagnosis is becoming increasingly routine for allergic human (but not animal) patients through single molecule CAP testing or the use of the ImmunoCAP ISAC112 microarray , where 28 of the 112 spotted molecules represent pollen allergen molecules.
In human patients rhinitis is the most prominent manifestation of pollen allergy, often in connection to conjunctivitis. Pollen allergies are associated with an oral allergy syndrome in 23% of cases . More importantly, according to the “united airways” principle there is a significant correlation of allergic rhinitis with asthma, prompting the ARIA (Allergic Rhinitis and its Impact on Asthma) –initiative by the World Allergy Organization . In human allergies pollen, in addition to house dust mites, animal dander and mold, play a dominant role. Pollen allergy has a more significant effect on the quality of life in patients than allergy to house dust mites, even up to several years after exposure , becoming worse when rhinitis is combined with asthma . Pollen allergy can be effectively treated by allergen immunotherapy, thereby enhancing the quality of life .
Pollen allergies in dog, cats and horses - seasonality
Generally, clinical signs of pollen allergy in these species tend to worsen seasonally if combined with other allergies, or in the case of pollen-only allergies, are strictly seasonal. Depending on the severity of clinical signs, a complete diagnostic work-up might be performed within the first season. In patients with a suggestive history and clinical signs of pollen allergy (see below for species-specific differences), the diagnostic work-up consists of ruling out any other differential diagnoses (e.g. parasites, flea allergy, food allergy and other species dependent disorders- e.g. Erythema multiforme in horses with signs of urticaria, or painful disorders in cats with self induced alopecia of the abdominal skin) (Figure 1). After this work-up, allergy testing using intradermal tests or serology (see below) is performed. In patients with known seasonal allergic disease in e.g. second season or even later, allergy testing is usually performed without ruling out other less probable differentials, such as food allergy.
Pollen allergies in the dog (Canis familiaris)
Pollen hypersensitivity is associated with Canine Atopic Dermatitis (CAD), a disease associated with high specific IgE against environmental allergens . Generally, pollen sensitization is believed to be of minor impact in allergic dogs even though classical studies indicated similar nasal congestion symptoms in humans and dogs, for instance to ragweed pollen exposure . The clinical picture differs from that of human rhinitis patients suffering from pollen allergy. In studies on nasal discharges in dogs, allergic rhinitis due to pollen allergens was excluded as a cause , rather nasal encounter with molds may play a role [14,15]. Thus according to veterinary practice, the canine allergic patient most often presents with pruritic allergic dermatitis (Figure 2). Here, differential diagnoses to e.g. food-induced allergic dermatitis have to be ruled out first. Either (for practical reasons) intradermal tests or determination of specific serum IgE lead then to the diagnosis of canine atopic dermatitis (Figure 1). Whenever pollen sensitization is diagnosed it may be associated with conjunctivitis in 21% of the dogs  and with rhinitis, but it is not associated with asthma [16,17]. The antigen-driven acute and chronic skin inflammation is usually termed CAD by the veterinary dermatologist, is seen independent of a true atopic background in the human sense, but associated with specific IgE . The nomenclature of canine allergic diseases reflects that the skin is the most prominently affected organ: CAD, food induced allergic dermatitis (FIAD), ALD atopic-like dermatitis (ALD), or FAD (Flea Allergy Dermatitis); (asthma and anaphylaxis in dogs are only seen in experimental models, in rare cases anaphylaxis may be drug- or insect venom-induced). Like in humans sensitizations may be associated with an atopic predisposition, which in dogs strongly varies depending on the breed. In a US study 9% of 30.000 investigated dogs showed signs of CAD, among them a series of breeds being at higher risk  (Table 1, Figure 3), such as the Labrador , Maltese or Shih-Tzu in a Korean study - where in fact sensitizations were mostly found to indoor but not pollen allergens . In a Swiss study, WHWT (White Wine terrier), boxer, French bulldog, Vizsla, bullterrier and Rhodesian ridgeback were at higher risk; additionally, pugs and Dalmatians were over-represented although without significance . Atopic predisposition may also enable early sensitization to outdoor allergens, as was shown in classical  and novel dog models where ragweed exposure lead to an asthmatic phenotype .
Pollen allergen sensitization in dogs is evaluated by intradermal skin testing (IDT), injecting the allergen extracts into the shaved skin of the lateral thorax or abdomen . Usually, the animals have therefore to be sedated or anesthetized. Reddishness, wheal and flare reactions of half of the size of the positive control (histamine) are interpreted as specific reaction. Generally, dogs react to pollen from grasses, trees and weeds (Table 2). The results of our literature research show a high variability in prevalence, probably caused by different geographic regions and lifestyle; insufficient data were found for cats and horses.
In contrast, a human allergist may get the impression that in veterinary practices IgE testing has a lower impact, due to a lack of standardized allergen extracts or reliable anti-dog IgE reagents. Interestingly, the human alpha chain of the high affinity receptor FcεRI is used in a commercial test for the detection of e.g. canine IgE . This is possible due to a 54% amino acid identity and 68% similarity among the human and canine alpha chain and precise knowledge of the amino acids involved in the IgE binding . To the best of our knowledge, the ISAC microarray testing has not been introduced into veterinary allergy diagnosis so far.
Specific sensitizations to pollen in canine versus human studies
In more than 1000 atopic dogs in Australia, a 10 to 25% sensitization to pollen of any kind (grass, tree, weed) was determined by intradermal tests . A more recent cross-sectional study in 651 atopic dogs indicated that sensitization between tree, weed and grass pollen, but not to other allergen sources, were in 94% of cases statistically associated . The authors pointed out that sensitization must clearly be distinguished from clinically relevant sensitization leading to symptoms.
No seasonal, sex or age dependent risk factors were observed in a recent comprehensive study of canine grass pollen sensitization in Western France . Importantly, like in humans, a significant increase in the number of dogs sensitized to grass pollen was observed, namely 14,4% between 1999 and 2002, and 27,7% between 2007 and 2010. More than 80% of the 262 tests were positive for one allergen out of 20-38 extracts tested (among them 4 grass pollen, 8 weed pollen and 17 tree pollen) and 21% for at least one pollen allergen. The diagnosis of the genuine sensitizing allergen may be complicated by cross reactivities. Müller et al. proposed that, although positive reactions among botanically closely related plant allergens may be significantly more common than those among nonrelated allergens, cross reactivity in 30% of the tested dogs was not pronounced enough to warrant testing and desensitization using allergen mixes [25,30].
Exposure to pollen depends on the local plant species, thus geographical differences enable distinct sensitizations. Masuda et al tested 42 Japanese atopic dogs by IDT and determined specific IgE using 26 allergen extracts from 8 allergen sources . Japanese cedar (Cryptomeria japonica) pollen, after house dust mites, was the second most important allergen in this area, with a sensitization prevalence of 50% and a positive IgE reactivity of 16,7% of tested pet dogs. The same sensitization pattern was seen in the Japanese human patients , where besides house dust mites, cedar pollen has become an important health challenge . In a more recent approach, the sensitization to single allergen molecules from Japanese cedar pollen were evaluated more precisely in a component-resolved manner in 15 dogs. Besides IgE to Japanese cedar molecules Cry j 1 and Cry j 3, 76% of tested dogs showed IgE to Cry j 6, hence identifying a new major canine allergen . Interestingly, in canine pollen allergy, an oral allergy syndrome to related foods can occur likely due to cross reactivity between cedar pollen and tomato , although this has only been reported sporadically. The results from a study in the Bangkok area used a mix of 24 different pollen types in 114 atopic dogs , but in this population pollen allergens seem to play a minor role as compared to dust mite, cockroach, ant and other insect allergens. This mirrors the situation in Thai children where the prevalence of grass pollen allergy was below 5% as compared to 50% house dust mite and 23% cockroach sensitization .
Clinical treatment: SIT
Interestingly, CAD is regularly and with significant success treated by the veterinary dermatologist through allergen immunotherapy . In fact, the International Task Force on Canine Atopic Dermatitis recommends offering SIT to each canine patient sensitized to environmental allergens including pollen . In human atopic eczema treatment SIT is a controversial topic, but here as well it may improve allergic symptoms even in settings of atopic predisposition . Generally, the dose and frequency of injections in allergic dogs were, at least in 2001, less harmonized than in human allergology  and were more recently compared in .
Pollen allergies in Cats (Felis catus domestica)
In a recent retrospective study of 45 Australian cats with atopic dermatitis, strong intradermal test reactions were most frequently seen to pollen allergens (61%) . In fact, in pollen-allergic cats the skin is most often affected by pruritic allergic /atopic lesions, but cats may also present with allergic rhinitis, such as the Japanese cat which was diagnosed with cedar pollinosis . Alternatively, cats with asthma may present with spastic coughing, where bronchoalveolar lavage as the next diagnostic step may reveal eosinophilic inflammation (Figure 1). Intradermal tests will lead then to the final diagnosis, whereas IgE determination has a lower impact.
The differential diagnosis in lower airway diseases associated with cough, respiratory distress, or both may be bronchitis or asthma, pneumonia, or neoplasms . Feline asthma is characterized by eosinophilic inflammation and cats have been used as animal models for human asthma [46,47]. One study reported that domestic mixed breeds, Abyssinian and Devon rex cats are predisposed, compared to the population of the dermatology referral service . The comprehensive central registry of all pet animals in Switzerland enabled the statistical evaluation in this study.
Clinical signs of cutaneous hypersensitivities in cats are not pathognomonic and include eosinophilic granuloma complex and self-induced hair-loss, and should be scored by an objective scale (SCORing Feline Allergic Dermatitis; SCORFAD) . The AD in cats is not necessarily connected with the levels of IgE or the diagnosis of specific IgE antibodies in serum . IgE to environmental allergens including pollen can be even found in pathogen-free housed cats [50,51]. When two groups of 10 cats each were intradermally tested, immediate reactivity was reported as IgE- as well as IgG-mediated reaction, but also explained by nonspecific mast cell degranulation . The authors proposed the prior injection of a fluorescent agent in order to enhance the fidelity of interpretation, a procedure connected with substantially higher strain for the animals. Even in early studies specific IgG directed against ryegrass pollen, in addition to flea and house dust mite allergens, was reported and proposed as the second Th2 antibody class of relevance in feline allergy . Rather than pollen, house dust mite allergens are found abundantly in the sleeping places of cats, but are not yet definitely proven to be causative allergens in feline AD or asthma .
Itchy inflammatory allergic skin diseases were successfully treated in 100 cats by daily oral immunosuppression with Cyclosporine over a six-week period . Generally, allergen immunotherapy is described for cats, but is not yet standard care in veterinary dermatology. This is possibly due to the fact that the underlying IgE-based diagnosis for identification of the relevant allergen still lacks sufficient specificity . Elimination diets, necessary for ruling out food hypersensitivities in cats and other species with non-seasonal cutaneous hypersensitivities, are usually performed prior to aeroallergen testing. These diets are more difficult to perform in cats than in dogs, so the owner often cannot follow through on one important step in diagnosing allergies. Another reason is that cats usually tolerate glucocorticoids much better than dogs. As mentioned above, Cyclosporine A is also a very useful drug in feline allergic dermatitis, since it is effective and achievable treatment option in these species [56,57].
A study using the human FcεRI alpha chain for detecting feline IgE , which has a 56% amino acid identity and 72% homology, resulted in the conclusion that IgE detection did not diagnose feline food or environmental allergies, but was effective in diagnosing insect hypersensitivities . Pilot studies with rush allergen immunotherapy with good tolerability were described in 4 cats . In 81 cats SIT significantly improved the dermatological conditions between 93.6% (linear granuloma) and 60% (self-induced hair loss), with an 86.1% improvement in asthma . Studies on subcutaneous versus mucosal (nasal) allergen immunotherapy or novel adjuvants were done in feline allergic asthma models, including Bermuda grass pollen. The authors reported improvement of the asthma, increase of the IL-4:IFN-gamma ratio and decline of bronchial eosinophils, as well as good tolerability . Reinero et al. reported that in cats allergen immunotherapy may be associated with induction of T-regulatory cells and IL-10, and also cross-protect to non-related allergens, such as Bermuda grass to house dust mite allergens .
Do horses (Equus caballus domesticus) suffer from pollen allergies?
In fact, horses do develop respiratory and skin diseases (urticaria, atopic eczema) due to allergens. Equine IgE can be detected by in vitro diagnosis. In this case the human alpha chain can also be used due to its 64% amino acid identity and 76% homology to the equine counterpart as evaluated by our own BLAST search. Moreover, in horses allergen immunotherapy is regularly done . Intradermal allergy tests or serum IgE tests may be chosen for further work-up and diagnosis for either skin or respiratory allergy (Figure 1).
Again, several breeds can be called atopic and therefore are more prone to allergies; in one study, Dutch warmbloods, Morgans, Swedish Warmbloods, Oldenburgs, Hackney horses, Paso finos, Polish Arabians and Arabian/Saddlebred cross were overrepresented  (Table 1, Figure 3). In equine allergic respiratory disease the symptoms may range from rhinitis and asthma to chronic dry cough and emphysema , indicating that numerous immediate-type, delayed-immune complex or cellular hyperreactivities can be causative in acute recurrent airway obstruction (RAO) or chronic obstructive pulmonary disease (COPD). For diagnosing RAO a lung function test is helpful. Positive correlations between symptom severity and exogenous factors such as climatic conditions, rainfall and seasonal pollen counts have been observed . Although recurrent obstruction may be clearly associated with the pollen season, the terminology is ‘obstructive pulmonary disease’, not asthma .
Additionally, pruritic skin diseases as well as recurrent urticaria may be observed in atopic horses. Furthermore, atopic dermatitis in equines is becoming a more commonly recognized disease, especially due to newer diagnostic methods and treatment options. It is interpreted in horses as an inherited predisposition to form specific antibodies to environmental allergens such as pollens of grasses, weeds and trees, but also to mold and dust. Clinical signs are pruritus and secondary intense self-trauma, crusting, alopecia with chronic lesions including lichenification and hyperpigmentation. Affected areas are often the ears, face, ventrum and legs. The clinical signs are similar to those caused by insect hypersensitivity and it is extremely common to have both diseases in the same horse .
Diagnosis of hypersensitivity in horses can be made based on clinical symptoms, ruling out other differential diagnoses (e.g. parasites, food hypersensitivities and insect hypersensitivities especially in the dermatologic patients), and by serology with specific IgE diagnosis and intradermal testing (Figure 1). It is substantial to differentiate between asthma and recurrent airway obstruction (RAO), as for the latter the contribution of IgE or IgG is still a matter of debate. In a recent study “reaginic” antibodies of the IgE and IgG class were described as participating in the pathophysiology of asthma and RAO , but also delayed type reactions were reported . Equine RAO studies mostly identified Aspergillus as a prominent allergen and include today component-resolved diagnosis [67,68]. It may be anticipated that a similar pathophysiological principle, IgE and IgG, will possibly account for pollen allergy. Later studies suggest that better diagnostic tools could improve the fidelity of equine allergy diagnosis. In an approach with 64 horses specific reactivity could be found to grass pollen allergens when antisera to peptides from equine IgE were used .
Heaves is a recurrent neutrophilic lung disease in horses with clinical similarity to asthma  but likely caused by molds from airborne dust and not by pollen . Interestingly, an enhanced apoptosis rate in CD4 and CD8 T-cells are seen in horses affected by RAO .
SIT can be performed in horses. For instance, 54 horses suffering from atopic skin diseases including urticaria and pruritus were treated with SIT successfully . Although 75% of horse owners decided to discontinue after a period of between 6 months and 8 years, approximately half of the discontinued horses profited from the therapy and stayed free from recurrence of clinical signs. The antigens used were extracts from Arizona cypress pollen, red cedar pollen, in addition to sheep epithelia, box elder, house dust mix, Dermatophagoides farinae, Dermatophagoides pteronyssinus, horsefly, flea, Culicoides, black ant, corn, grain mill dust and grain smut. Of the 27 horses that were reported to benefit from SIT, 13 horses had their SIT formulated based on the results of IDT, nine had their SIT based on a serum test, and five had both an IDT and a serum test. A chi-square analysis used to compare the success proportions of SIT between skin tests, serum tests and both showed no statistical difference between the three groups.
Pollen allergens in human allergic patients are mainly responsible for rhinitis and asthma, whereas in canines they predominantly cause canine atopic dermatitis, in cats rhinitis, asthma and dermatitis, and in horses recurrent urticaria, pruritic dermatitis and recurrent airway obstruction (in the latter species not called asthma). Generally, allergenic pollens that cause human disease are relevant for our domestic animals, at least for dogs (Table 2). The human and veterinary diagnosis differs slightly depending on the species, but clinical pictures are similar (Figures 1 and 2). Several breeds are at a significantly higher risk of developing allergic diseases (Table 1, Figure 3). IgE testing with extracts or molecules represents an indispensable cornerstone in human allergy diagnosis, but has not yet reached the same high fidelity in IgE testing of allergic dogs, cats and horses. This may be due to distinct pathomechanisms or a lack of optimized diagnostic tools. Therefore, in animals intradermal tests rather than epidermal prick tests are important tools for allergy diagnosis. In animals, but not in human allergic patients, the IgE test and intradermal test are regarded equal and may replace each other . Allergen immunotherapy is a reliable instrument to reduce clinical symptoms both in humans and their allergic domestic animals.
Allergic Rhinitis and its Impact on Asthma
Canine atopic dermatitis
Chronic obstructive pulmonary disease
Flea allergy dermatitis
Food induced allergic dermatitis
Intradermal skin test
Recurrent airway obstruction
SCORing feline allergic dermatitis
(allergen-) specific immunotherapy
Skin prick test
Schafer T, Merkl J, Klemm E, Wichmann HE, Ring J. We and our pets: allergic together? Acta Vet Hung. 2008;56:153–61.
Bousquet PJ, Burbach G, Heinzerling LM, Edenharter G, Bachert C, Bindslev-Jensen C, et al. GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy. 2009;64:1656–62.
Necas M. Atopy patch testing with airborne allergens. Acta Dermatovenerol Alp Panonica Adriat. 2013;22:39–42.
Heinzerling L, Frew AJ, Bindslev-Jensen C, Bonini S, Bousquet J, Bresciani M, et al. Standard skin prick testing and sensitization to inhalant allergens across Europe–a survey from the GALEN network. Allergy. 2005;60:1287–300.
Canonica GW, Ansotegui IJ, Pawankar R, Schmid-Grendelmeier P, van Hage M, Baena-Cagnani CE, et al. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6:17.
Dondi A, Tripodi S, Panetta V, Asero R, Businco AD, Bianchi A, et al. Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity. Pediatr Allergy Immunol. 2013;24:742–51.
Bousquet J, Schunemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130:1049–62.
Kiotseridis H, Cilio CM, Bjermer L, Tunsater A, Jacobsson H, Dahl A. Grass pollen allergy in children and adolescents-symptoms, health related quality of life and the value of pollen prognosis. Clin Transl Allergy. 2013;3:19.
Delgado J, Davila ID, Dominguez-Ortega J, Quirce S, Marti-Guadano E, Valero A. Quality of life in patients with respiratory allergy is influenced by the causative allergen. J Investig Allergol Clin Immunol. 2013;23:309–14.
Petersen KD, Kronborg C, Larsen JN, Dahl R, Gyrd-Hansen D. Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days. World Allergy Organ J. 2013;6:15.
Halliwell R. Revised nomenclature for veterinary allergy. Vet Immunol Immunopathol. 2006;114:207–8.
Tiniakov RL, Tiniakova OP, McLeod RL, Hey JA, Yeates DB. Canine model of nasal congestion and allergic rhinitis. J Appl Physiol (1985). 2003;94:1821–8.
Plickert HD, Tichy A, Hirt RA. Characteristics of canine nasal discharge related to intranasal diseases: a retrospective study of 105 cases. J Small Anim Pract. 2014;55:145–52.
Barrs VR, van Doorn TM, Houbraken J, Kidd SE, Martin P, Pinheiro MD, et al. Aspergillus felis sp. nov., an emerging agent of invasive aspergillosis in humans, cats, and dogs. PLoS One. 2013;8:e64871.
Mercier E, Peters IR, Billen F, Battaille G, Clercx C, Day MJ, et al. Potential role of Alternaria and Cladosporium species in canine lymphoplasmacytic rhinitis. J Small Anim Pract. 2013;54:179–83.
Favrot C, Steffan J, Seewald W, Picco F. A prospective study on the clinical features of chronic canine atopic dermatitis and its diagnosis. Vet Dermatol. 2010;21:23–31.
Furiani N, Scarampella F, Martino PA, Panzini I, Fabbri E, Ordeix L. Evaluation of the bacterial microflora of the conjunctival sac of healthy dogs and dogs with atopic dermatitis. Vet Dermatol. 2011;22:490–6.
Halliwell RE, DeBoer DJ. The ACVD task force on canine atopic dermatitis (III): the role of antibodies in canine atopic dermatitis. Vet Immunol Immunopathol. 2001;81:159–67.
Lund EM, Armstrong PJ, Kirk CA, Kolar LM, Klausner JS. Health status and population characteristics of dogs and cats examined at private veterinary practices in the United States. J Am Vet Med Assoc. 1999;214:1336–41.
Owczarek-Lipska M, Lauber B, Molitor V, Meury S, Kierczak M, Tengvall K, et al. Two loci on chromosome 5 are associated with serum IgE levels in Labrador retrievers. PLoS One. 2012;7:e39176.
Kim HJ, Kang MH, Park HM. Common allergens of atopic dermatitis in dogs: comparative findings based on intradermal tests. J Vet Sci. 2011;12:287–90.
Picco F, Zini E, Nett C, Naegeli C, Bigler B, Rufenacht S, et al. A prospective study on canine atopic dermatitis and food-induced allergic dermatitis in Switzerland. Vet Dermatol. 2008;19:150–5.
Mapp C, Hartiala J, Frick OL, Shields RL, Gold WM. Airway responsiveness to inhaled antigen, histamine, and methacholine in inbred, ragweed-sensitized dogs. Am Rev Respir Dis. 1985;132:292–8.
Royer CM, Rudolph K, Barrett EG. The neonatal susceptibility window for inhalant allergen sensitization in the atopically predisposed canine asthma model. Immunology. 2013;138:361–9.
Mueller RS, Bettenay SV, Tideman L. Aero-allergens in canine atopic dermatitis in southeastern Australia based on 1000 intradermal skin tests. Aust Vet J. 2000;78:392–9.
Stedman K, Lee K, Hunter S, Rivoire B, McCall C, Wassom D. Measurement of canine IgE using the alpha chain of the human high affinity IgE receptor. Vet Immunol Immunopathol. 2001;78:349–55.
Ye H, Housden JE, Hunter M, Sabban S, Helm BA. Identification of amino acid residues involved in the interaction of canine IgE with canine and human FcepsilonRIalpha. Mol Immunol. 2014;57:111–8.
Buckley L, Schmidt V, McEwan N, Nuttall T. Cross-reaction and co-sensitization among related and unrelated allergens in canine intradermal tests. Vet Dermatol. 2013;24:422–7.
Roussel AJ, Bruet V, Bourdeau PJ. Characterisation of dog sensitisation to grass pollen in western France from 1999 to 2010. Vet Rec. 2013;172:686.
Mueller RS, Chapman PL. Cross reactivity of airborne allergens based on 1000 intradermal test results. Aust Vet J. 2004;82:351–4.
Masuda K, Sakaguchi M, Fujiwara S, Kurata K, Yamashita K, Odagiri T, et al. Positive reactions to common allergens in 42 atopic dogs in Japan. Vet Immunol Immunopathol. 2000;73:193–204.
Kusunoki T, Korematsu S, Harazaki M, Ito M. Hosoi S: [Recent pollen sensitization and its possible involvement in allergic diseases among children in a pediatric allergy clinic]. Arerugi. 1999;48:1166–71.
Fujieda S, Kurono Y, Okubo K, Ichimura K, Enomoto T, Kawauchi H, et al. Examination, diagnosis and classification for Japanese allergic rhinitis: Japanese guideline. Auris Nasus Larynx. 2012;39:553–6.
Kubota S, Miyaji K, Shimo Y, Shimakura H, Takase Y, Okamoto N, et al. IgE reactivity to a Cry j 3, an allergen of Japanese cedar (Cryptomeria japonica) pollen in dogs with canine atopic dermatitis. Vet Immunol Immunopathol. 2012;149:132–5.
Fujimura M, Ohmori K, Masuda K, Tsujimoto H, Sakaguchi M. Oral allergy syndrome induced by tomato in a dog with Japanese cedar (Cryptomeria japonica) pollinosis. J Vet Med Sci. 2002;64:1069–70.
Chanthick C, Anaman S, Buathet K. The prevalence of positive intradermal allergy tests in 114 dogs with atopic dermatitis in the Bangkok metropolis, Thailand. Vet Immunol Immunopathol. 2008;126:256–62.
Yuenyongviwat A, Koonrangsesomboon D, Sangsupawanich P. Recent 5-year trends of asthma severity and allergen sensitization among children in southern Thailand. Asian Pac J Allergy Immunol. 2013;31:242–6.
Hobi S, Mueller RS. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2014;42:167–73.
Olivry T, DeBoer DJ, Favrot C, Jackson HA, Mueller RS, Nuttall T, et al. International Task Force on Canine Atopic D: Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol. 2010;21:233–48.
Darsow U. Allergen-specific immunotherapy for atopic eczema: updated. Curr Opin Allergy Clin Immunol. 2012;12:665–9.
Griffin CE, Hillier A. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. Vet Immunol Immunopathol. 2001;81:363–83.
Loewenstein C, Mueller RS. A review of allergen-specific immunotherapy in human and veterinary medicine. Vet Dermatol. 2009;20:84–98.
Ravens PA, Xu BJ, Vogelnest LJ. Feline atopic dermatitis: a retrospective study of 45 cases (2001-2012). Vet Dermatol. 2014;25:95–102.
Masuda K, Kurata K, Sakaguchi M, Yamashita K, Hasegawa A, Ohno K, et al. Seasonal rhinitis in a cat sensitized to Japanese cedar (Cryptomeria japonica) pollen. J Vet Med Sci. 2001;63:79–81.
Johnson LR, Vernau W. Bronchoscopic findings in 48 cats with spontaneous lower respiratory tract disease (2002-2009). J Vet Intern Med. 2011;25:236–43.
Lee-Fowler TM, Cohn LA, DeClue AE, Spinka CM, Reinero CR. Evaluation of subcutaneous versus mucosal (intranasal) allergen-specific rush immunotherapy in experimental feline asthma. Vet Immunol Immunopathol. 2009;129:49–56.
Reinero CR, Cohn LA, Delgado C, Spinka CM, Schooley EK, DeClue AE. Adjuvanted rush immunotherapy using CpG oligodeoxynucleotides in experimental feline allergic asthma. Vet Immunol Immunopathol. 2008;121:241–50.
Steffan J, Olivry T, Forster SL, Seewald W. Responsiveness and validity of the SCORFAD, an extent and severity scale for feline hypersensitivity dermatitis. Vet Dermatol. 2012;23:410–e477.
Belova S, Wilhelm S, Linek M, Beco L, Fontaine J, Bergvall K, et al. Factors affecting allergen-specific IgE serum levels in cats. Can J Vet Res. 2012;76:45–51.
Loft KE, Pedersen K. The presence of pollen and house dust mite allergen-specific IgE in serum of 15 SPF cats and prevalence of house dust mite allergens (Dermatophagoides pteronyssinus 1, Dermatophagoides farinae 1, and mite group 2) in their microenvironment. Vet Dermatol. 2007;18:184.
Loft KE, Rosser Jr EJ. Group 1 and 2 Dermatophagoides house dust mite allergens in the microenvironment of cats. Vet Dermatol. 2010;21:152–8.
Schleifer SG, Willemse T. Evaluation of skin test reactivity to environmental allergens in healthy cats and cats with atopic dermatitis. Am J Vet Res. 2003;64:773–8.
Foster AP, O’Dair HA, DeBoer DJ. Allergen-specific IgG antibodies in cats with allergic skin disease. Res Vet Sci. 1997;63:239–43.
King S, Favrot C, Messinger L, Nuttall T, Steffan J, Forster S, et al. A randomized double-blinded placebo-controlled study to evaluate an effective ciclosporin dose for the treatment of feline hypersensitivity dermatitis. Vet Dermatol. 2012;23:440–e484.
Reinero CR. Feline immunoglobulin E: historical perspective, diagnostics and clinical relevance. Vet Immunol Immunopathol. 2009;132:13–20.
Wisselink MA, Willemse T. The efficacy of cyclosporine A in cats with presumed atopic dermatitis: a double blind, randomised prednisolone-controlled study. Vet J. 2009;180:55–9.
Ganz EC, Griffin CE, Keys DA, Flatgard TA. Evaluation of methylprednisolone and triamcinolone for the induction and maintenance treatment of pruritus in allergic cats: a double-blinded, randomized, prospective study. Vet Dermatol. 2012;23:387–e372.
Trimmer AM, Griffin CE, Boord MJ, Rosenkrantz WS. Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats. Vet Dermatol. 2005;16:324–9.
Halliwell RE. Efficacy of hyposensitization in feline allergic diseases based upon results of in vitro testing for allergen-specific immunoglobulin E. J Am Anim Hosp Assoc. 1997;33:282–8.
Reinero C, Lee-Fowler T, Chang CH, Cohn L, Declue A. Beneficial cross-protection of allergen-specific immunotherapy on airway eosinophilia using unrelated or a partial repertoire of allergen(s) implicated in experimental feline asthma. Vet J. 2012;192:412–6.
Fadok VA. Update on equine allergies. Vet Clin North Am Equine Pract. 2013;29:541–50.
Stepnik CT, Outerbridge CA, White SD, Kass PH. Equine atopic skin disease and response to allergen-specific immunotherapy: a retrospective study at the University of California-Davis (1991-2008). Vet Dermatol. 2012;23:29–35.
Francqueville M. Sabbah A: [Allergic rhinitis in the horse: first case]. Allerg Immunol (Paris). 1990;22:56–60.
Ward MP, Couetil LL. Climatic and aeroallergen risk factors for chronic obstructive pulmonary disease in horses. Am J Vet Res. 2005;66:818–24.
Dixon PM, McGorum B. Pasture-associated seasonal respiratory disease in two horses. Vet Rec. 1990;126:9–12.
Griffin C. Equine skin diseases that every practitioner should know about. In: 27th Annual Congress of the ESVD-ECVD; Salzburg, Austria. 2014.
Tahon L, Baselgia S, Gerber V, Doherr MG, Straub R, Robinson NE, et al. In vitro allergy tests compared to intradermal testing in horses with recurrent airway obstruction. Vet Immunol Immunopathol. 2009;127:85–93.
Scharrenberg A, Gerber V, Swinburne JE, Wilson AD, Klukowska-Rotzler J, Laumen E, et al. IgE, IgGa, IgGb and IgG(T) serum antibody levels in offspring of two sires affected with equine recurrent airway obstruction. Anim Genet. 2010;41 Suppl 2:131–7.
Kalina WV, Pettigrew HD, Gershwin LJ. IgE ELISA using antisera derived from epsilon chain antigenic peptides detects allergen-specific IgE in allergic horses. Vet Immunol Immunopathol. 2003;92:137–47.
Aharonson-Raz K, Lohmann KL, Townsend HG, Marques F, Singh B. Pulmonary intravascular macrophages as proinflammatory cells in heaves, an asthma-like equine disease. Am J Physiol Lung Cell Mol Physiol. 2012;303:L189–198.
Pirie RS. Recurrent airway obstruction: A review. Equine Vet J. 2014;46(3):276–88.
Moran G, Folch H, Henriquez C, Ortloff A, Barria M. Reaginic antibodies from horses with recurrent airway obstruction produce mast cell stimulation. Vet Res Commun. 2012;36:251–8.
Zur G, White SD, Ihrke PJ, Kass PH, Toebe N. Canine atopic dermatitis: a retrospective study of 169 cases examined at the University of California, Davis, 1992-1998. Part II. Response to hyposensitization. Vet Dermatol. 2002;13:103–11.
Nesbitt GH. Canine allergic inhalant dermatitis: a review of 230 cases. J Am Vet Med Assoc. 1978;172:55–60.
Nesbitt GH, Kedan GS, Cacciolo P. Canine atopy. Ethiology and diagnosis. Compendium on Continuing Education Practice Vet. 1984;6:73–85.
Sture GH, Halliwell RE, Thoday KL, van den Broek AH, Henfrey JI, Lloyd DH, et al. Canine atopic disease: the prevalence of positive intradermal skin tests at two sites in the north and south of Great Britain. Vet Immunol Immunopathol. 1995;44:293–308.
Stursberg U. Felines Asthma und chronische Bronchitis: Untersuchungen zu Anamnese, Allergiediagnostik und Therapie mit Propentofyllin. Tierärztliche Fakultät: LMU München; 2010.
Kolm-Stark G, Wagner R. Intradermal skin testing in Icelandic horses in Austria. Equine Vet J. 2002;34:405–10.
Temizel EM, Aytug N. Intradermal Testing Results and Clinical Features in Dogs with Atopic Dermatitis in Turkey. J Biol Environ Sci. 2011;5:87–9.
We thank Ms. Amelia Wein for proofreading. Further, we are much obliged to Mr. Michael Bernkopf for pictures of three dog breeds, and Mrs. Sibylle Gref for providing pictures of Devon cats. Further we would like to thank all those who provided great animal pictures under the public domains and w:de:Creative Commons license on www.pixabay.com and http://commons.wikimedia.org/ which enabled us to compose Figure 3.
This work was supported by grants from the Austrian Science Fund FWF: SFB F4606-B19 and MCCA W1248-B13.
The authors declare that they have no competing interests.
EJJ: Study design and writing of the manuscript. LE: Help in writing of the manuscript, design of tables and literature research. IH: Advice in veterinary aspects of allergy, help in literature research, design of tables and writing of the manuscript. JT: Advice in study design and scientific contributions to manuscript writing. LP: Clinical and scientific advice in veterinary aspects of allergy, help in literature research, and writing of the manuscript. All authors read and approved the final manuscript.